BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar DN, Chaudhuri A, Aqil F, Dehari D, Munagala R, Singh S, Gupta RC, Agrawal AK. Exosomes as Emerging Drug Delivery and Diagnostic Modality for Breast Cancer: Recent Advances in Isolation and Application. Cancers 2022;14:1435. [DOI: 10.3390/cancers14061435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Tenchov R, Sasso JM, Wang X, Liaw W, Chen C, Zhou QA. Exosomes─Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. ACS Nano 2022. [DOI: 10.1021/acsnano.2c08774] [Reference Citation Analysis]
2 Chaudhuri A, Ramesh K, Kumar DN, Dehari D, Singh S, Kumar D, Agrawal AK. Polymeric micelles: A novel drug delivery system for the treatment of breast cancer. Journal of Drug Delivery Science and Technology 2022;77:103886. [DOI: 10.1016/j.jddst.2022.103886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hussen BM, Faraj GSH, Rasul MF, Hidayat HJ, Salihi A, Baniahmad A, Taheri M, Ghafouri-Frad S. Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy. Cancer Cell Int 2022;22:323. [PMID: 36258195 DOI: 10.1186/s12935-022-02743-3] [Reference Citation Analysis]
4 Yang T, Zhai J, Hu D, Yang R, Wang G, Li Y, Liang G. "Targeting Design" of Nanoparticles in Tumor Therapy. Pharmaceutics 2022;14:1919. [PMID: 36145668 DOI: 10.3390/pharmaceutics14091919] [Reference Citation Analysis]
5 Chaudhuri A, Kumar DN, Shaik RA, Eid BG, Abdel-Naim AB, Md S, Ahmad A, Agrawal AK. Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy. Int J Mol Sci 2022;23:10068. [PMID: 36077466 DOI: 10.3390/ijms231710068] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kumar DN, Chaudhuri A, Dehari D, Shekher A, Gupta SC, Majumdar S, Krishnamurthy S, Singh S, Kumar D, Agrawal AK. Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer. Life (Basel) 2022;12:1143. [PMID: 36013322 DOI: 10.3390/life12081143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Joglekar AV, Dehari D, Anjum MM, Dulla N, Chaudhuri A, Singh S, Agrawal AK. Therapeutic potential of venom peptides: insights in the nanoparticle-mediated venom formulations. Futur J Pharm Sci 2022;8. [DOI: 10.1186/s43094-022-00415-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Matsuzaka Y, Yashiro R. Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications. Membranes 2022;12:550. [DOI: 10.3390/membranes12060550] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, Kumar D, Agrawal AK. Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 2022;15:542. [DOI: 10.3390/ph15050542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]